In endometrial carcinoma, METTL14 overexpression promotes methylation modification via an m6A-YTHDF2-dependent mechanism, reducing GPX4 mRNA stability, increasing lipid peroxidation levels, and acceler- ating ferroptosis. Here, GPX4 is linked to endometrial carcinoma.